Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: When/how did TPL acquire legal or beneficial ownership?

From the Master Agreement

Page 4

WHEREAS, to resolve the Inventorship Litigation and disagreements among

the parties, provide funds to Patriot to finance its operations, and provide for

the effective commercialization of the MSD Patents, the parties have agreed

that:

C. As soon as possible after the date hereof, Patriot, TPL and Moore will

settle all litigation among them pursuant to the Stipulated Final Judgment

substantially in the form attached hereto as Exhibit A (the "Stipulated Final

Judgment"), and will take any and all action necessary to cause the trade

secrets litigation currently pending between Patriot and TPL in Santa Clara

Superior Court (the "Trade Secrets Litigation") to be dismissed without

prejudice, and the Infringement Litigation involving Intel and Patriot shall be

dismissed with prejudice;

4.6 Intellectual Property

(a) TPL has a valid and subsisting license to the MSD Patents from

Moore. Except as disclosed on Schedule 4.6(a), TPL has not received any notice

or claim challenging TPL's rights with respect to the MSD Patents or suggesting

that any Person, other than Patriot and Moore, has any claim of legal or

beneficial ownership with respect thereto, nor, to TPL's knowledge, is there a

reasonable basis for any such claim.

Share
New Message
Please login to post a reply